- Open Access
Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions
Retrovirologyvolume 10, Article number: 59 (2013)
Live attenuated SIV induces potent protection against superinfection with virulent virus; however the mechanism of this vaccine effect is poorly understood. Such knowledge is important for the development of clinically acceptable vaccine modalities against HIV.
Using a novel, doxycycline dependent, replication-competent live-attenuated SIVmac239Δnef (SIV-rtTAΔnef), we show that under replication-permissive conditions SIV-rtTAΔnef is fully viable. Twelve rhesus macaques were infected with a peak plasma vRNA on average two log10 lower than in 6 macaques infected with unconditionally replication-competent SIVΔnef. Consistent with the attenuated phenotype of the viruses the majority of animals displayed low or undetectable levels of viraemia by 42-84 days after infection. Next, comparison of circulating T cells before and after chronic infection with parental SIVΔnef revealed a profound global polarisation toward CD28-CCR7- T-effector memory 2 (TEM2) cells within CD95+CD4+ and CD95+CD8+ populations. Critically, a similar effect was seen in the CD95+ CD4+ population and to somewhat lesser extent in the CD95+ CD8+ population of SIV-rtTAΔnef chronically infected macaques that were maintained on doxycycline, but was not seen in animals from which doxycycline had been withdrawn. The proportions of gut-homing T-central memory (TCM) and TEM defined by the expression of α4β7 and CD95 and differential expression of CD28 were increased in CD4 and CD8 cells under replication competent conditions and gut-homing CD4 TCM were also significantly increased under non-permissive conditions. TEM2 polarisation was seen in the small intestines of animals under replication permissive conditions but the effect was less pronounced than in the circulation. Intracellular cytokine staining of circulating SIV-specific T cells for IL-2, IFN-γ, TNF-α and IL-17 showed that the extent of polyfunctionality in CD4 and CD8 T cells was associated with replication permissivity; however, signature patterns of cytokine combinations were not distinguishable between groups of macaques.
Taken together our results show that the global T memory cell compartment is profoundly skewed towards a mature effector phenotype by attenuated SIV. Results with the replication-conditional mutant suggest that maintenance of this effect, that may be important in vaccine design, might require persistence of replicating virus.
Because of the predilection of human and simian immunodeficiency viruses to replicate in cells of the immune system and particularly in CD4 T cells it is an extremely complex task to unravel the exact relationships between viral dynamics, influenced by virus and host phenotype and the cognate adaptive and innate immune responses. These responses are themselves influenced directly by virus replication and bystander effects driven by inappropriate immune activation and immunosuppression. It is however clear that T cell immune responses have a profound influence on on-going virus replication as evidenced by (1) the temporal relationship between their appearance and the down-turn in concentrations of plasma vRNA [1, 2], (2) the strong selective pressure exerted on T cell epitope recognition [3, 4] and (3) experiments in SIV-infected macaques where selective depletion of CD8 T cells correlated with reduced virus control [5, 6]. Conversely, the generation of T cell responses is driven by virus replication and antigen expression which themselves are modulated by the effects of the virus on the integrity of the immune system including continuous immune activation characterised by increased T cell turnover, the production of pro-inflammatory cytokines and distinct B cell dysfunction [7–9]. Moreover, it is now realised that infection has a profound and early impact on the gut epithelial barrier associated with local inflammation and loss of integrity of the mucosal immune system. Since the gut accommodates a rich environment of microbes and microbial products, its damage may cause increased permeability and translocation of microbial products into the periphery fuelling continuous systemic immune activation, a hallmark of HIV/SIV pathogenesis [10, 11].
The use of SIV mutants in the macaque model allows the dissection of the complex interplay between the host and virally-encoded pathogenesis factors and has been critical in revealing the ability of attenuated virus to induce a state of superinfection resistance in vivo. It is well established that removal or interruption of the viral accessory gene nef attenuates HIV and SIV in vivo resulting in the early acute phase viraemia progressing to a very low set-point where virus rarely if ever is detected in the peripheral circulation either by virus isolation from peripheral blood mononuclear cells (PBMC) or by RT-PCR amplification of vRNA [12, 13]. This attenuated peripheral phenotype of viral replication is associated with the generation of CD8 and CD4 T cell responses which are widely disseminated and detectable at mucosal sites regardless of the virus portal of entry. Moreover, macaques infected with attenuated SIV display potent resistance to subsequent superinfection challenge with cell-free homologous and heterologous viruses including chimeric SIV expressing HIV envelope [14–16] and virus infected cells . Furthermore, protection extends to mucosal challenge [16, 18, 19]. Even when superinfection does occur, disease progression appears to be ameliorated by the effects of the pre-existing attenuated virus . Although, taken together, these findings suggest that live attenuated vaccination would be an approach to vaccination against HIV safety issues including reversion to virulence by mutation  and differential pathogenicity dependent upon host factors  have precluded direct development of this strategy. Nonetheless, mechanistic insight into this powerful effect will inform rational design of clinically acceptable vaccines.
To more fully understand the live attenuated vaccine effect it is imperative to define the parameters required for protection. As for other attenuated virus vaccines it is known that protection is influenced by the degree of attenuation, as reflected in the acute peak of plasma viraemia [22, 23]. However, less is known about events following clearance of attenuated virus from the peripheral circulation. In this study we were interested to determine the attenuated vaccine-driven T cell environment and cognate T cell responses under conditions where on-going replication in tissues (occult replication) was permitted compared to non-replication permissive conditions. To address this issue we have used a novel conditionally replication competent variant of SIVmac239Δnef (SIVΔnef): a prototypic attenuated SIV that confers potent protection against superinfection . The conditional mutant, designated SIVmac239rtTAΔnef (SIV-rtTAΔnef), replicates exclusively when doxycycline (dox) is administered in vitro[24, 25].
We show here in rhesus macaques that SIV-rtTAΔnef replicated in vivo in the presence of orally administered dox and drives polarisation of the global circulating T cell memory compartment toward a TEM phenotype, most notably in the fully differentiated TEM2 population (CD95+CD28-CCR7-). A similar effect was seen in SIVΔnef -infected macaques. Critically this phenotype was not seen following withdrawal of dox in SIV-rtTAΔnef -infected macaques i.e. under replication non-permissive conditions. Maintenance of gut-homing α4+β7+ TEM (CD95+CD28-) also was dependent on replication permissivity whereas increased proportions of CD4 and CD8 α4+β7+ TCM (CD95+CD28+) were observed in SIV-rtTAΔnef -infected macaques in both the continued presence of dox and following withdrawal of dox. Analysis of small intestine tissues demonstrated marked differences in vRNA and Env antigen staining intensity and distribution between macaques infected with SIV-rtTAΔnef under replication permissive and non-permissive conditions and animals infected with SIVΔnef; however, polarisation of global T cell memory phenotypes was less pronounced in cells extracted from small intestine. Analysis of SIV-antigen driven T cell polyfunctionality revealed no clearly defined IL-2, IFN-γ, TNF-α and IL-17 signature with respect to virus replication dynamics at the level of individual cytokine combinations in either CD4 or CD8 circulating or small intestinal T cell populations; however, the degree of polyfunctionality was related to replicative capacity and replication permissivity.
SIV-rtTAΔnef had an attenuated phenotype in vivo with reduced acute phase replication compared to SIVΔnef
A total of 12 macaques, pre-dosed with dox for 14 days were inoculated with SIV-rtTAΔnef and maintained on dox for a further 175 days (Groups A & B). Six animals were followed for a further 56 days following withdrawal of dox (Group A) and a further 6 animals were inoculated with SIVΔnef in the absence of dox (Group C). All animals were successfully infected resulting in median peak plasma vRNA loads of 4.34 × 103 (range 9.44 × 102 – 2.49 × 104) vRNA copies/ml for SIV-rtTAΔnef and 2.95 × 105 (range 1.32 × 104 – 7.73 × 105) vRNA copies/ml for SIVΔnef (Figure 1); the median peak load being significantly lower in SIV-rtTAΔnef -infected macaques (ρ = 0.001, Mann–Whitney rank sum test). Otherwise, in general, plasma vRNA load kinetics followed a typical attenuated pattern with an acute peak typically 14 days post infection (p.i.); although occasionally as late as 28 days p.i. followed by a rapid decline with vRNA dropping below the limit of detection between 42 and 84 days p.i. and remaining undetectable or with transient peaks of <120 vRNA/copies/ml thereafter. SIV-rtTAΔnef -infected macaques E65 and E70, both with delayed peak viraemia (28 days p.i.), had relatively high “set points” of >100 vRNA copies/ml, although in E65, levels had declined by 140 days p.i. Surprisingly however, despite withdrawal of dox from 175 days p.i., two transient peaks of plasma viraemia were detected in this animal. Macaque E74, infected with SIVΔnef, exhibited a high set-point of approximately 103 copies/ml and macaque E76, despite an initial decline in vRNA, displayed a progressive rebound of plasma vRNA.
PCR analysis of PBMC revealed that, with one exception (E61), infected macaques had a peak of proviral DNA 14- 22 days p.i. regardless of the infecting virus; however, the median peak frequency of proviral DNA was significantly lower (ρ < 0.001, Mann Whitney rank sum test) in macaques infected with SIV-rtTAΔnef (4.38 copies/105 cell equivalents) compared with animals infected with SIVΔnef (371copies/105 cell equivalents) (Figure 1). Following withdrawal of dox from Group A, proviral DNA was undetectable in 3 macaques but detected transiently and at <5 copies/105 cell equivalents in the remaining 3 SIV-rtTAΔnef -infected macaques.
Comparison of peak and day 175 plasma vRNA and proviral DNA concentrations showed no statistical differences between Groups A and B (vRNA peak: ρ =0.31; vRNA d175: ρ =0.94; proviral DNA peak: ρ =0.39; proviral DNA d175: ρ =0.31, Mann–Whitney rank sum test) indicating no significant differences in virological changes between these groups of animals before cessation of dox.
Differential localisation of SIV-rtTAΔnef and SIVΔnefin tissues
Two animals from each group were killed humanely 230 days p.i. (Group A; 56 days after withdrawal of doxycycline) or 160-167 days p.i. (Groups B & C) for analysis of bio-distribution and T cell composition in small intestine. Proviral DNA was detected in all tissues analysed from macaques infected with SIVΔnef, generally at concentrations exceeding those in PBMC (Table 1). Likewise animals infected with SIV-rtTAΔnef and maintained on dox had widely distributed proviral DNA but concentrations overall were lower than those in animals of Group C, particularly in spleen and mesenteric lymph nodes. A further reduction in proviral DNA concentration was seen in the spleens and peripheral lymph nodes of the two SIV-rtTAΔnef-infected macaques from which dox had been withdrawn. Proviral DNA was not detected in the thymus of SIV-rtTAΔnef -infected animals and was detected in the small intestine in only one animal, when dox was maintained. To investigate further whether persisting proviral DNA was transcriptionally active with or without doxycycline quantitative rtPCR was performed on cellular RNA isolated from spleen, PLN and MLN samples. Detectable signals between 102 and 105 copies per 50 ng total RNA were detected in these tissues in E74 infected with SIVΔnef and a signal of 248 copies per 50 ng total RNA from E78 also infected with the same virus. Amongst macaques infected with the doxycycline dependent SIV-rtTA Δnef signals just above the cut-off value of the assay (20 copies per 50 ng total RNA) were detected in selected tissues from E69 and E72 that were still receiving doxycycline. No signals above cut-off were detected in macaques infected with SIV-rtTA Δnef where doxycycline had stopped being administered 56 days before the tissues were analysed.
Since the small intestine is a major site for virus replication we were interested to determine bio-distribution in this tissue. Haematoxylin and eosin staining revealed no gross pathology regardless of virus status (data not shown). Next, sections of small intestine from each animal were examined by immunohistochemistry using an SIV-Env specific monoclonal antibody for the presence of SIV envelope (Figure 2a-c). Group A macaques had very low levels of envelope detection throughout all regions of the small intestine including Peyer’s patches. By contrast Group B & C macaques demonstrated moderate levels of envelope detection within Peyer’s patches and associated germinal centres, extending to nearby crypts in Group C animals.
The presence of SIV-infected cells within the small intestine was examined by in situ hybridisation using a cocktail of three probes complementary with SIV RNA transcripts (Figure 2d-f). Whilst SIV positive cells were detected within the small intestine of all animals the numbers and positioning of these cells differed between groups. Sections of small intestine from Group A animals contained very low levels of SIV productively-infected cells within T cell areas of the lamina propria. Analysis of sections from Group B and Group C small intestine demonstrated the presence of increased numbers of SIV positive cells within Peyer’s patches with those from Group B animals being present largely within the marginal/mantle zones surrounding secondary follicle germinal centres and those within Group C animals being mainly clustered within the germinal centres themselves.
Active replication of attenuated SIV reconfigured the composition of the memory T cell compartment
To investigate the impact of infection on memory T cell phenotype, T central memory (TCM) and T effector memory (TEM) were enumerated on CD3+CD4+ and CD3+CD8+ -gated populations by staining for expression of CD95 and CD28 according to Pitcher et al.,  (Figure 3a). CD4+ T cells from macaques infected with SIVΔnef, showed a statistically significant reduction (ρ = 0.013; paired t-test) in TCM (CD95+, CD28+) with a concomitant increase (ρ = 0.004; paired t-test) in the proportion of TEM. A similar trend was seen in animals infected with SIV-rtTAΔnef under replication permissive conditions but did not reach statistical significance; whereas, under replication non-permissive conditions, following withdrawal of dox, only random changes were seen (Figure 3b, c). In the CD8 memory T cell populations, a similar trend was seen although statistical significance was reached only in the increase in the proportions of TEM in animals infected with SIV-rtTA maintained on dox (ρ = 0.024; paired t-test) (Figure 3d, e).
Next, we determined the expression of CD28 and CCR7 on CD95+ CD4+ and CD8+ T cells. Thus memory cell populations were defined along the TCM to TEM differentiation axis according to Picker et al[27, 28] as T central memory (TCM) CD28+CCR7+; transitional effector memory (TEM1) CD28+CCR7- and fully differentiated effector memory (TEM2) CD28-CCR7-. Both SIV-rtTAΔnef -dox-maintained and SIVΔnef -infected animals, displayed a strong polarisation to a global CD4+ TEM2 phenotype, with a corresponding significant reduction in TCM frequency (Figure 4). Similar trends were observed in the CD8+ T cell populations; although statistical significance was reached only in SIVΔnef -infected animals. In addition a significant polarisation toward TEM1 was seen in both CD4 and CD8 cells from animals infected with SIVΔnef with only animal E77 being an exception; whereas, only a proportion of infected-animals of group B had an increase in this subset. Of particular note, global polarisation toward TEM2 was not evident in animals of Group A, indicating that replication-permissive conditions were necessary for the maintenance of this phenotype.
To investigate whether SIV- or dox-induced translocation of microbial products from the gut may be driving the extensive T cell polarisation observed, LPS and sCD14 were quantified by ELISA in plasma from naïve dox-treated, SIV-rtTAΔnef, SIVΔnef and wild-type SIV-infected animals. LPS was undetectable and concentrations of sCD14 were close to undetectable in all animals except those infected with wild-type SIV (Additional file 1: Figure S1). Furthermore, the proportions of CD4+ and CD8+ T cells with effector memory phenotype in the blood of these animals fell within the ranges measured in non-dox treated naïve macaques.
Viral replication imprinted expression of the gut homing marker α4β7 on CD95+T cells
Because the gut associated lymphoid tissue (GALT) is a primary site of SIV and HIV replication regardless of the viral route of entry  and the α4β7 integrin, specifically expressed on gut-homing T cells, is upregulated in SIV/HIV infection  and may play an important role in pathogenesis, we were interested to determine the effect of viral replication status on α4β7 subsets. Infection with either SIV-rtTAΔnef or SIVΔnef induced α4+β7+ CD4+CD95+ and CD8+CD95+ TCM and TEM subsets although the change in CD4+ TEM cells failed to reach statistical significance the result was skewed by macaque E67, which also was an exception in the CD8+ TEM population (Figure 5). Interestingly, while active viral replication was necessary to maintain α4+β7+ TEM in both CD4 and CD8 populations, α4β7 expression was imprinted on CD4 and CD8 TCM from the majority of animals infected with SIV-rtTAΔnef from which dox had been withdrawn for 56 days i.e. under non-permissive conditions for viral replication.
Gut-resident T cells from macaques with actively replicating SIV were polarised toward TEM2but less so than were circulating T cells
Next, we analysed T cell phenotypes in MNC isolated from the small intestines of two animals from each group at necropsy together with cells from two uninfected, dox-dosed animals as controls. There was no evidence of SIV-induced reduction in the proportion of CD4+ cells in the small intestine with the possible exception of E78 (infected with SIVΔnef); although higher frequencies of CD8+ T cells were observed in all SIV-infected animals compared with controls. Interestingly, the profound global polarisation toward TEM1 and particularly TEM2 phenotype seen in the blood of animals under replication permissive conditions was less apparent in the small intestine. Nonetheless, the overall trend was similar with respect to the fully matured TEM2 phenotype but was not evident in the intermediate TEM1 populations of CD4+ and CD8+ cells (Table 2).
Total polyfunctionality of SIV-specific peripheral T cells was associated with replication permissivity but group-specific cytokine signatures were not evident
Having established that replication permissive conditions were associated with driving the peripheral and to some extent the small intestinal global T cell population toward a TEM2 phenotype in both the CD4 and CD8 compartments, we sought to determine whether replication permissivity influenced the quality and quantity of SIV-specific T cells. Following stimulation in vitro with SIV Gag, Rev or Tat peptide pools, polychromatic flow cytometry was employed to analyse intracellular staining for IFN-γ, IL-2, TNF-α, and IL-17. First, we determined the proportion of macaques in each group showing maximum polyfunctionality, regardless of frequency or individual antigen specificity. Thus, for CD4+ T cells 50 percent of the SIVΔnef-infected animals exhibited the highest degree of polyfunctionality, whereas 66.6% of animals infected with SIV-rtTAΔnef maintained on dox had a maximum of 3 functions and 1 of 6 and 2 of 6 animals infected with SIV-rtTAΔnef from which dox had been withdrawn had 4 or 3 functions respectively (Figure 6a). For CD8+ T cells, all animals of Group C had polyfunctional cells, 50% of Group B animals had 4 functions and the remaining animals had 3 functions and 50% of animals from Group A had 4 functions but the remaining animals each had 3, 2 or 1 functions (Figure 7a). Taken together, these results indicate that the likelihood of exhibiting SIV-polyfuctionality with respect to the cytokines analysed was associated with the replicative capacity and status of the infecting virus.
Next, we sought to determine whether SIVΔnef and SIV-rtTAΔnef-infected macaques under replication permissive and non-permissive had distinguishable patterns of SIV antigen-specific T cell cytokine responses as it may be possible eventually to identify protective T cell signatures. The frequencies of SIV-specific cytokine secreting cells were analysed with respect to all combinations of cytokines for each infection group. In both CD4+ and CD8+ populations there was a high degree of animal to animal variability in cell frequency regardless of virological status (Figures 6b & 7b) and a high degree of variability in the proportion of animals with reactive cells for each cytokine combination (Figures 6c & 7c); however, there was a trend to higher overall polyfunctionality in CD8+ cells, most notably in animals under replication permissive conditions. CD4+ IL-17+ cells were found principally as single secretors, particularly in rtTA dox-maintained animals and in combination with TNF-α; whereas, CD8+ IL-17+ cells were virtually absent in all groups (Figure 7).
The relatively small sample size precluded detailed statistical analysis at the level of individual cytokine combinations and antigen specificity with respect to individual cell frequencies; therefore the data was analysed by principal component analysis with respect to CD4 and CD8 expression, frequency and proportion of SIV-specific responses to the 15 combinatorial cytokine patterns. Although several outlier individuals were evident, overall no signature pattern was recognised with respect to spatial clustering by infection group (Additional file 2: Figure S2).
Total SIV-specific T cell frequencies were higher in the small intestine compared with the peripheral circulation and polyfunctionality was maintained under replication non-permissive conditions
Flow cytometric analysis of intracellular cytokine stained (ICS) T cells revealed that MNC contained higher frequencies of SIV-specific T cells than were measured in the peripheral circulation of the corresponding animals (Figure 8). Sufficient cells were available from only one of two animals from Groups A and C respectively that went to necropsy examination. Nonetheless, interestingly, E64 (SIV-rtTAΔnef, dox withdrawn) had few, if any, circulating SIV-specific T cells whereas CD4+ T cells in the small intestine were predominantly IL-2, TNF-α, IL17, and IL2, IFN-γ, TNF-α triple positive at high frequency. Likewise, CD8+ small intestinal T cells from E64 had a high proportion of polyfunctional cells at high frequency including ~20% expressing all 4 cytokines. Although the overall frequency of antigen-specific T cells was invariably higher in the small intestine compared with the peripheral circulation (ρ < 0.001; paired t-test), the proportion of polyfunctional cells and the frequency combination was variable between the two compartments. Again, it was not possible to discern any specific signature of responsiveness either between compartments or between animals from different groups.
We have used a novel replication-conditional SIV-rtTAΔnef to compare in vivo the influence of infection on the global T memory cell compartment and the frequency of SIV-specific polyfunctional T cells under replication permissive and non-permissive conditions at times when, in the majority of macaques, vRNA was undetectable in the circulation. Results were compared to those obtained from macaques infected with the parental SIVΔnef. The SIV-rtTAΔnef construct had previously been optimised for replication in rhesus macaque PBMC through evolution in vitro without loss of dox-control . Here we have shown that this construct is fully infectious in vivo in rhesus macaques and induces a similar overall pattern of plasma vRNAemia to SIV-Δnef. The higher acute phase replication of the non-rtTA variant virus likely accounts for the higher proviral loads detected particularly in spleen and mesenteric lymph nodes of animals infected with this virus compared with those infected with SIV-rtTAΔnef. Interestingly, lower proviral loads were detected in spleen and peripheral lymph nodes from dox-withdrawn animals, suggesting a higher turnover of SIV-infected CD4+ T cells in these tissues, which may therefore be primary sites of occult replication. Evidence of proviral transcription was seen in peripheral lymph nodes of macaques E69 and E72 and the spleen of E72 which were infected with SIV-rtTAΔnef and maintained on dox. Similar activity was absent in the two macaques sampled from which dox was withdrawn; however, this analysis is limited by the sample size. Interestingly, much higher levels of SIV gag transcripts were detected in the spleen and peripheral lymph nodes of macaque E74 and the peripheral lymph nodes of macaque E78; likely reflecting the higher replicative fitness of SIVΔnef. Detection of vRNA by in situ hybridisation and Env antigen by immunocytochemistry in the absence of proviral DNA in the small intestines of SIV-rtTA infected animals, albeit at very low levels in dox-withdrawn animals, probably reflects the sensitivity of these techniques to detect localized pockets of infection in tissue that is otherwise free from SIV-infected cells. Relatively high levels of Env staining were observed in dox-maintained animals and in animals infected with SIV-Δnef with those Env positive tissue regions not correlating to sites of viral replication likely demonstrating trapping of antigen by local antigen presenting cells including follicular dendritic cells. It is also interesting to note that sites of viral replication within the small intestine were subtly different between these groups of animals.
The reduction in peak viraemia and reduced proviral load in PBMC seen with SIV-rtTAΔnef compared with SIVΔnef demonstrates that despite optimisation of the virus in vitro, the addition of the rtTA element had a fitness-cost in vivo. Interestingly, two macaques infected with SIV-rtTAΔnef and 2 macaques infected with SIVΔnef displayed persisting plasma viraemia. We have observed a similar effect in rhesus macaques using a minimally nef-deleted virus ; however, the extent of nef -deletion in the constructs used here make a direct repair of the attenuating lesion impossible. Surprisingly, transient low level plasma vRNA was detected in one SIV-rtTA-infected macaque (E65) after withdrawal of dox. Interestingly, this animal displayed persistence of plasma vRNAemia at >102 copies ml-1 for over 100 days p.i. One possible explanation could be that a compensatory mutation for viral transactivation may have arisen in progeny virus within this animal; however, only minor changes, which do not affect the dox control were found in the LTR promoter and rtTA regions (data not shown). Very low levels of vRNA and Env protein were detected in the small intestines of dox-withdrawn animals which could be due to basal activity of the LTR promoter in the absence of dox. This promoter lacks a functional TAR element but contains the natural NF-Kappa-B and Sp1 binding sites, which are not sufficient to drive viral replication but may drive low-level gene expression [24, 25]. Furthermore, in some cells the proviral LTR promoter may be activated by transcriptional enhancer elements present at or near the site of integration.
There was no evidence of elevated serum soluble CD14 (Additional file 1: Figure S1); an indicator of loss of intestinal epithelium integrity reported in chronic pathogenic infection with HIV and wild-type SIV [11, 31]. Neither was there evidence of histopathological changes in the gut of those animals sampled, including one animal with persistent viraemia. Nonetheless, within the global circulating CD95+ T cell population there was a striking polarisation toward an effector memory phenotype in animals where virus replication was permissible. This result is consistent with data showing that SIVΔnef-infection pushes the SIV-specific CD4 T cell response toward TEM; however, unexpectedly, the skewing effect described here applies to the global CD4 population, regardless of antigen specificity, and was also seen in the CD8+ T cell population, albeit to a lesser extent. This polarising effect was particularly apparent when the CCR7 receptor, important for secondary lymphoid tissue homing, was used to differentiate TCM. Although macaques in group A had a higher baseline proportion of CD4+ TEM2 than those of Group B, these values fell within the range for all naïve macaques including those of Group C. Given the extent of the polarising effect seen in Groups B and C the pre-existing baseline values in Group A were unlikely to have influenced the result obtained after infection but this cannot be absolutely ruled out. Since only a small proportion of T cells are infected with SIV, it is evident that the skewing of immunophenotype must be acting on bystander cells, either through SIV-encoded soluble products such as Env and Tat, through SIV-encoded products released from dead and dying cells or from mediators arising as a result of SIV-induced dysregulation of lymphoid system homeostasis. Whatever the exact mechanism, which is likely to be multifactorial, our data suggest that on-going virus replication, albeit occult, is required to maintain TEM polarisation. It is likely that there is a critical threshold of replication required to drive perturbation of the global T memory phenotype as (1) the effect is strongest, extending to both CD4+ and CD8+ T cells in macaques infected with SIVΔnef,; (2) not all macaques infected with SIV-rtTAΔnef demonstrated the majority effect in the presence of dox i.e. macaque E68 had increased CD4 TEM1, no significant increase in TEM2 and no proportionate loss of TCM and displayed similar trends in CD8+ memory T cells and (3) despite the transient detection of plasma vRNA under dox-withdrawal in macaque E65 this animal did not demonstrate significant perturbation of memory phenotype while macaque E66 demonstrated a skewing toward an increased frequency of CD4+ TEM1.
SIVΔnef induces α4β7+ gut mucosal-homing CD8+ T lymphocytes  and more recent studies with HIV have shown that α4β7 on CD4+ T cells may have a central role in pathogenesis through interaction with gp120 and signalling . Moreover, α4+β7hi memory T cells are preferentially infected during acute pathogenic SIV infection  and blocking α4β7 during acute infection decreases local and plasma virus loads . In the study described here, analysis of expression of α4β7 on CD28+ and CD28- populations of CD95+ CD4 and CD8 T cells showed that SIV infection in the majority of animals significantly increased the proportion of mucosal homing cells. Interestingly this effect appeared less dependent upon on-going occult virus replication for maintenance of CD95+ CD28+ T cells expressing α4β7 suggesting that these cells may be long-lived. In contrast, animals infected with non-attenuated SIVmac239 failed to show elevated proportions of CD95 CD28+ α4+β7+ CD4 cells, although the proportions of α4+β7+ TCM CD8 cells were increased (data not shown). This observation is consistent with α4β7 expression on circulating CD4+ T cells being a surrogate marker of CD4+ T cell loss in the gut . Indeed the proportion of CD4+ small-intestinal MNC were not decreased in attenuated SIV-infected macaques, even in animal E74 with a persistent plasma viraemia; whereas, the proportion of CD8+ cells was elevated. Furthermore the relatively low proportions of small intestinal CD4+ T cells and high proportions of CD8+ T cells in uninfected animals is similar to results reported recently . It is interesting that the replication-dependent TEM polarisation seen in the peripheral circulation was less pronounced in the GALT and was confined to the terminally differentiated TEM2 population; however, the small sample size limits interpretation of this observation.
Antigen-specific polyfunctional CD8+ T cell responses have been associated with positive control of immunodeficiency virus infection, for example in HIV-1 long term non-progressors ; however, the extent to which these types of responses are important in the SIV live-attenuated vaccine model is less clear. Also the relative role of polyfunctional CD4+ T cell responses needs further investigation. Infection of macaques with the novel SIV-rtTAΔnef as described here may help to address these issues. The finding that overall there were no consistent differences in the patterns of cytokine combinations in CD4+ and CD8+ circulating T cells between the groups of macaques in the present study suggests that the repertoire of T cell polyfunctionality in the circulation is determined whilst virus is under replication-permissive conditions and was not overtly influenced by the lower peak viraemia observed in rtTA-infected animals. Although, only selected regions of the viral genome were examined in this study at a single time point, it is unlikely that significant differences between the groups would be missed. Interestingly IL-17-producing CD4+ and CD8+ cells were present in the gut and peripheral circulation despite their reported paucity following infection with virulent SIVmac [39, 40] reflecting the attenuated nature of the viruses used in this study. It was notable that, in the small number of macaques studied, the polyfunctionality of SIV-specific T cells was notably different in individual animals when comparing systemic and gut mucosal responses possibly reflecting regional diversification of the T cell immune response. The lack of particular signatures of T cell polyfunctionality in the macaques may reflect the use of outbred animals where there is greater plasticity of immune responsiveness than seen in inbred species, such as mouse strains, frequently used for immunological analysis of functional correlates in infection.
Overall, this study has shown that live attenuated SIV infection drives a global polarisation of T cell memory phenotype, particularly in the CD4 population toward effector memory. Moreover, maintenance of this effect likely requires on-going replication that is largely undetectable in the circulation. Although replication non-permissive conditions were associated with loss of perturbation of circulating TEM, these conditions had little, if any, effect on T cell polyfunctionality, at least with respect to the cytokines examined. It will now be important to determine whether these changes in T cell subsets influence the ability of animals infected with live attenuated SIV to resist superinfection with virulent virus thus informing rational design of vaccines against HIV. Recent findings in macaques vaccinated with recombinant rhesus cytomegalovirus expressing SIV genes strongly suggest that SIV-specific TEM are crucial to early control of SIV following challenge . Moreover, whilst this paper was in preparation, it has been reported that lymph node effector-differentiated T cell responses predict the efficacy of live attenuated SIV vaccines . Further work is required to formally address the absolute requirement for dox in vivo, particularly with respect to the possibility of low-level basal transcription. The SIV-rtTAΔnef construct should be useful to address issues such as whether constant or intermittent tissue associated virus replication is necessary to maintain TEM frequency at protective levels.
Animals and viruses
UK captive-bred rhesus macaques (Macaca mulatta) of Indian origin, aged between 38 & 42 months at the start of the experiment, were housed and maintained in accordance with the Home Office (UK) Code of Practice (1998). The study was approved by the NIBSC Ethics Committee. Animals were sedated with ketamine hydrochloride prior to procedures. Plasma concentrations of dox were monitored ex vivo using a previously described assay .
Stocks of SIVmac239Δnef (SIVΔnef) and SIV-rtTAΔnef were grown on CEMX174 cells and stored at -70°C as cell-free supernatants. The construction and optimization of SIV-rtTAΔnef containing the rtTA-V16 variant with increased dox-sensitivity and activity was described previously [24, 25, 44]. Viral titres were determined using C8166 cells. Twelve macaques receiving 100 mg dox daily per oral were inoculated intravenously with 104 TCID50 SIV-rtTAΔnef. After175 days dox was withdrawn from six of the animals (Group A). Animals maintained on dox for the duration of the experiment were designated Group B. A further 6 animals were inoculated intravenously with 104 TCID50 SIVΔnef (Group C). All animals were sampled regularly for peripheral blood.
Quantification of SIV RNA and proviral DNA
Quantitative real-time RT-PCR targeted to SIV gag was used to determine plasma viral load as described previously with a limit of detection of 50 SIV RNA/genome equivalents copies per ml . Tissue samples were digested with proteinase K and phenol/chloroform following standard protocols according to . After DNA extraction, qPCR was performed using Taqman Universal PCR Master mix (Applied Biosystems) and primers and complementary probes with sequences located in conserved gag regions as reported for the qRT-PCR assay. SIV proviral DNA concentrations were calculated using the Mx3005P software, expressed as copies of SIV DNA per 105 PBMC/mononuclear cells (MNC). A single SIV DNA copy determined the limit of assay detection, as determined by Poisson statistics and as previously reported .
Mononuclear cell isolation from peripheral blood and small intestinal tissue
Peripheral blood mononuclear cells (PBMC) were separated from 10 to 20 ml heparinised whole blood by Percoll gradient centrifugation. Small intestinal tissue (approximately 30 g) was cut into small pieces (1-2 cm) and digested with collagenase IV (Sigma). Tissue mononuclear cells (MNC) were isolated using Percoll density gradient. Briefly, pieces of tissues were washed in calcium and magnesium-free HBSS (Gibco) for 20 min at 37°C. Cells released in suspension were considered intra-epithelial lymphocytes (IEL). For lamina propria lymphocytes (LPL), pieces of tissue were further digested with 50 μg/ml collagenase IV and 100 μg/ml DNAase (Sigma) and passed through a mesh (70 mm pore size). The resulting material was treated with 2 mg/ml DNAase at 37°C for 30 min and MNCs were isolated using Percoll. Cells were re-suspended in FCS/RPMI for analysis. Due to low cell yields, IELs and LPLs from small intestinal tissue were pooled for analysis.
Immunohistochemical and In situHybridisation Analyses
Representative sections of lymphoid tissues and small intestine were collected post mortem, fixed in 10% formal saline and embedded in paraffin wax using standard histological procedures. Four micron sections were cut and mounted on poly-L lysine coated slides. Prior to any treatment sections were de-waxed in xylene and re-hydrated via graded ethanol:water solutions. Sections were then stained with haematoxylin and eosin using standard histochemical procedures. In situ hybridisation for the detection of SIV RNA transcripts was performed with digoxigenin (dig; Roche, Lewes, UK) labelled single stranded DNA probes  in a cocktail containing either three probes normal to or three probes complementary with SIV transcripts using a BondMax automated staining machine, utilising the Research Mode option for protocol design and execution (Leica Microsystems USA) . Quantification of ISH positive cells was performed by manually counting all positive cells within up to 10 random fields of view (×10 lens and ×10 eyepiece magnification; equivalent to 2.2 mm2) and data calculated as the mean number of positive cells per mm2.
Immunohistochemical analyses were performed on a BondMax automated staining machine. Sections were treated using a 30 min HIER1 unmasking protocol and stained using a Bond Polymer Refine staining system and protocol (Leica Microsystems, USA) incorporating an addition blocking treatment step (20 minutes at room temperature using 20% normal horse serum, 1× casein (Vector Laboratories) in 10 mM Tris/1 mM EDTA pH 7.6) prior to the addition of KK13 monoclonal antibody specific for SIVgp120 . Degrees of tissue staining were graded and used to generate mean scores within each group of two animals.
Immunophenotyping and intracellular cytokine staining
Peripheral and gut mononuclear cells were simultaneously surface stained with anti-CD3-V500 (clone SP32, BD Horizon), anti-CD4-V450 (clone L200, BD Horizon), anti-CD8-APCCy7 (clone SK1, BD Biosciences), anti-CD95-PECy7 (DX2, BioLegend), anti-CD28-PerCP-Cy5.5 (eBiosciences), anti-CCR7-FITC (R&D systems), anti-β7-APC (BD Biosciences) and anti-CD49d-PE (α4, BD Biosciences).
SIV-specific cellular immune responses were assessed using multiparametric intracellular cytokine staining (ICS) as described . Briefly, thawed PBMCs were washed and re-suspended at 2 × 106 cells/ml in RPMI 1640/10% FCS medium. Cells were then plated with 1 mg/ml CD49d, 1 mg/ml anti-CD28, Golgi Stop (10 ng/ml, BD), and either 5 μg/ml of 15mer SIV Gag or Tat or Rev pooled peptides (CFAR/NIBSC, Potters Bar, UK) and incubated at 37°C in a 5% CO2 environment with RPMI 1640/10% FCS for 14 h. PBMC were incubated with 10 ng/ml of PMA (Sigma) and 1 μg/ml ionomycin (Sigma) as positive controls. A negative control containing MNC and co-stimulatory antibodies without the peptide mix, was also included in each assay. After 2 hours, 10 ng/ml monensin (BD Biosciences) was added to all cultures. After incubation, cells were surface-stained with anti-CD4-PECy7, anti-CD8-Alexa 488 and anti-CD3 V500 (BD Biosciences), washed with PBS/2% FCS and fixed and permeabilised with Fix and Perm kit (Caltag). Intracellular cytokines were detected using anti-IFN-γ-PErCPCy5.5 (clone B27, BioLegend), anti-IL-2-PE (MQ1-17H21, ebiosciences), anti-TNF-α APC (MAB11, eBiosciences) and anti-IL-17A-Pacific Blue (BioLegend). Finally, cells were washed, fixed in PBS containing 1.5% paraformaldehyde (Sigma) and stored at 4°C prior analysis. All samples were analysed by flow cytometry (BD Canto II) within 24 h. Instrument set up and data acquisition procedures were performed according to BD Immunocytometry Systems protocols. More than 200,000 and 50,000 events respectively were acquired per sample, within the lymphocyte population of PBMC and gut-derived MNC samples. Electronic compensation was applied using antibody-capture beads (BD Biosciences) stained separately with individual monoclonal antibodies. Data were analysed using BD FACS Diva software. Lymphocyte subpopulations were identified by gating on CD3+ cells and subsequently delineating CD4, CD8, CD95, CCR7, CD28 and α4β7 expression. CD4 gating delineated a CD4high population, by excluding weakly positive events (events located in regions of low contour density, e.g. reference ). In this way, non-conventional T cells such as NKT cells are excluded from the analysis. For the identification of T cell memory subsets, CD4+ and CD8+ cells were represented on contour plots depicting staining intensity for the CD95 and CD28 parameters. A quadrant was set according to fluorochrome/contour intensity  and used to discriminate between the 4 phenotypic combinations. Differential expression of CCR7 and CD28 was similarly determined using a gating protocol based on that of Picker et al., .
To determine T cell polyfunctional cytokine responses to SIV Gag, Rev and Tat peptide pools, a combination of sequential plots were used delineating frequencies of TNF-α, IL-2, IFN-γ and IL-17 expressing cells. Background responses detected in negative control samples were subtracted for every specific functional combination. A threshold of >0.01% total CD4+ or CD8+ T cells responding after subtraction of background was used as a cut-off [52, 53].
Statistical analyses, as specified, were performed using Sigma Plot 11 (Systat Software, Inc.) and principal component analysis was used to determine any signature patterns of responsiveness (SSPS).
Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994, 68 (9): 6103-6110.
Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994, 68 (7): 4650-4655.
Kaur A, Alexander L, Staprans SI, Denekamp L, Hale CL, McClure HM, Feinberg MB, Desrosiers RC, Johnson RP: Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol. 2001, 31 (11): 3207-3217. 10.1002/1521-4141(200111)31:11<3207::AID-IMMU3207>3.0.CO;2-H.
Soudeyns H, Paolucci S, Chappey C, Daucher MB, Graziosi C, Vaccarezza M, Cohen OJ, Fauci AS, Pantaleo G: Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur J Immunol. 1999, 29 (11): 3629-3635. 10.1002/(SICI)1521-4141(199911)29:11<3629::AID-IMMU3629>3.0.CO;2-O.
Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999, 283 (5403): 857-860. 10.1126/science.283.5403.857.
Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999, 189 (6): 991-998. 10.1084/jem.189.6.991.
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996, 271 (5255): 1582-1586. 10.1126/science.271.5255.1582.
Silvestri G, Feinberg MB: Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest. 2003, 112 (6): 821-824.
De Milito A, Morch C, Sonnerborg A, Chiodi F: Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS. 2001, 15 (8): 957-964. 10.1097/00002030-200105250-00003.
Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004, 200 (6): 749-759. 10.1084/jem.20040874.
Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006, 12 (12): 1365-1371.
Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 1992, 258 (5090): 1938-1941. 10.1126/science.1470917.
Rud EW, Cranage M, Yon J, Quirk J, Ogilvie L, Cook N, Webster S, Dennis M, Clarke BE: Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol. 1994, 75 (Pt 3): 529-543.
Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, Daniel MD: Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1989, 86 (16): 6353-6357. 10.1073/pnas.86.16.6353.
Nilsson C, Makitalo B, Thorstensson R, Norley S, Binninger-Schinzel D, Cranage M, Rud E, Biberfeld G, Putkonen P: Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS. 1998, 12 (17): 2261-2270. 10.1097/00002030-199817000-00006.
Cranage MP, Whatmore AM, Sharpe SA, Cook N, Polyanskaya N, Leech S, Smith JD, Rud EW, Dennis MJ, Hall GA: Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology. 1997, 229 (1): 143-154. 10.1006/viro.1996.8419.
Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet. 1995, 345 (8961): 1342-1344. 10.1016/S0140-6736(95)92540-6.
Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y: Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol. 1997, 71 (3): 1911-1921.
Tenner-Racz K, Stahl Hennig C, Uberla K, Stoiber H, Ignatius R, Heeney J, Steinman RM, Racz P: Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci USA. 2004, 101 (9): 3017-3022. 10.1073/pnas.0308677101.
Whatmore AM, Cook N, Hall GA, Sharpe S, Rud EW, Cranage MP: Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol. 1995, 69 (8): 5117-5123.
Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN: Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med. 1999, 5 (2): 194-203. 10.1038/5557.
Johnson RP, Lifson JD, Czajak SC, Cole KS, Manson KH, Glickman R, Yang J, Montefiori DC, Montelaro R, Wyand MS: Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol. 1999, 73 (6): 4952-4961.
Mori K, Yasutomi Y, Ohgimoto S, Nakasone T, Takamura S, Shioda T, Nagai Y: Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: Robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain. J Virol. 2001, 75 (9): 4023-4028. 10.1128/JVI.75.9.4023-4028.2001.
Das AT, Klaver B, Harwig A, Vink M, Ooms M, Centlivre M, Berkhout B: Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication. J Virol. 2007, 81 (20): 11159-11169. 10.1128/JVI.01354-07.
Das AT, Klaver B, Centlivre M, Harwig A, Ooms M, Page M, Almond N, Yuan F, Piatak M, Lifson JD: Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Retrovirology. 2008, 5: 44-10.1186/1742-4690-5-44.
Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ: Development and homeostasis of T cell memory in rhesus macaque. J Immunol. 2002, 168 (1): 29-43.
Picker LJ, Reed-Inderbitzin EF, Hagen SI, Edgar JB, Hansen SG, Legasse A, Planer S, Piatak M, Lifson JD, Maino VC: IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest. 2006, 116 (6): 1514-1524. 10.1172/JCI27564.
Grossman Z, Picker LJ: Pathogenic mechanisms in simian immunodeficiency virus infection. Curr Opin HIV AIDS. 2008, 3 (3): 380-386. 10.1097/COH.0b013e3282fbaae6.
Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science. 1998, 280 (5362): 427-431. 10.1126/science.280.5362.427.
Cromwell MA, Veazey RS, Altman JD, Mansfield KG, Glickman R, Allen TM, Watkins DI, Lackner AA, Johnson RP: Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol. 2000, 74 (18): 8762-8766. 10.1128/JVI.74.18.8762-8766.2000.
Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M, Barclay GR, Smedley J, Pung R, Oliveira KM: Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010, 6 (8): e1001052-10.1371/journal.ppat.1001052.
Gauduin MC, Yu Y, Barabasz A, Carville A, Piatak M, Lifson JD, Desrosiers RC, Johnson RP: Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection. J Exp Med. 2006, 203 (12): 2661-2672. 10.1084/jem.20060134.
Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D, Xiao Z, Veenstra TD, Conrad TP, Lempicki RA: HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol. 2008, 9 (3): 301-309. 10.1038/ni1566.
Kader M, Wang X, Piatak M, Lifson J, Roederer M, Veazey R, Mattapallil JJ: Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2009, 2 (5): 439-449. 10.1038/mi.2009.90.
Ansari AA, Reimann KA, Mayne AE, Takahashi Y, Stephenson ST, Wang R, Wang X, Li J, Price AA, Little DM: Blocking of alpha4beta7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol. 2011, 186 (2): 1044-1059. 10.4049/jimmunol.1003052.
Wang X, Xu H, Gill AF, Pahar B, Kempf D, Rasmussen T, Lackner AA, Veazey RS: Monitoring alpha4beta7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection. Mucosal Immunol. 2009, 2 (6): 518-526. 10.1038/mi.2009.104.
Schultheiss T, Schulte R, Sauermann U, Ibing W, Stahl-Hennig C: Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues. Retrovirology. 2011, 8: 24-10.1186/1742-4690-8-24.
Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006, 107 (12): 4781-4789. 10.1182/blood-2005-12-4818.
Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, Ferrari MG, Zaffiri L, Tryniszewska E, Tsai WP, Vaccari M: Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008, 1 (4): 279-288. 10.1038/mi.2008.14.
Nigam P, Kwa S, Velu V, Amara RR: Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J Immunol. 2011, 186 (2): 745-753. 10.4049/jimmunol.1002807.
Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T: Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature. 2011, 473 (7348): 523-527. 10.1038/nature10003.
Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Iii MD: Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat Med. 2012, 18 (11): 1673-1681. 10.1038/nm.2934.
Kleibeuker W, Zhou X, Centlivre M, Legrand N, Page M, Almond N, Berkhout B, Das AT: A sensitive cell-based assay to measure the doxycycline concentration in biological samples. Hum Gene Ther. 2009, 20 (5): 524-530. 10.1089/hum.2008.182.
Zhou X, Vink M, Klaver B, Berkhout B, Das AT: Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther. 2006, 13 (19): 1382-1390. 10.1038/sj.gt.3302780.
Berry N, Stebbings R, Ferguson D, Ham C, Alden J, Brown S, Jenkins A, Lines J, Duffy L, Davis L: Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J Gen Virol. 2008, 89 (Pt 9): 2240-2251.
Berry N, Herrera C, Cranage M: Detection, quantification, and characterisation of HIV/SIV. Methods Mol Biol. 2011, 665: 133-160.
Canto-Nogues C, Jones S, Sangster R, Silvera P, Hull R, Cook R, Hall G, Walker B, Stott EJ, Hockley D: In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo. J Gen Virol. 2001, 82 (Pt 9): 2225-2234.
Clarke S, Berry N, Ham C, Alden J, Almond N, Ferguson D: Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques. J Neurovirol. 2012, 18 (2): 100-112. 10.1007/s13365-012-0084-3.
Kent KA, Gritz L, Stallard G, Cranage MP, Collignon C, Thiriart C, Corcoran T, Silvera P, Stott EJ: Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS. 1991, 5 (7): 829-836. 10.1097/00002030-199107000-00006.
Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G: Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med. 2007, 204 (6): 1405-1416. 10.1084/jem.20062363.
Petrovas C, Yamamoto T, Gerner MY, Boswell KL, Wloka K, Smith EC, Ambrozak DR, Sandler NG, Timmer KJ, Sun X: CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest. 2012, 122 (9): 3281-3294. 10.1172/JCI63039.
Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR: Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol. 2007, 81 (16): 8468-8476. 10.1128/JVI.00228-07.
Genesca M, Rourke T, Li J, Bost K, Chohan B, McChesney MB, Miller CJ: Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. J Immunol. 2007, 179 (7): 4732-4740.
We thank Mario Roederer and Jakub Kopycinski for their help with graphical presentation of polychromatic flow cytometry data using SPICE, David Lovell for the principal component analysis and the staff of the NIBSC Biological Facilities Unit for their excellent veterinary and husbandry skills. The study was funded by grants from the International AIDS Vaccine Initiative (IAVI) and the AIDS Fonds (grant 2005022). The contributions of MP, JH, DF and NA were supported, in part, by funding from the NIHR Centre for Research in Health Protection at the Health Protection Agency, UK. MSM and MPC were supported by the Sir Joseph Hotung Trust. The study was integrated with efforts to standardise HIV vaccine development through the EUROPRISE Network of Excellence on Microbicides and Vaccines.
The authors declare that they have no competing interests.
MM carried out flow cytometric analysis, contributed to experimental design and drafting the manuscript. NB and CH carried out the molecular virology in the animal studies and contributed to the manuscript, DF designed and carried out immunocytochemistry and ISH and provided input to the manuscript. RS participated in designing and interpreting immune-phenotyping., MR, MP and BL contributed to acquisition and preparation of biological specimens and virological results. AD and BB prepared constructs and performed sequence analysis, NA, BB, and MC conceived of the study, participated in its design and coordination. MC took overall responsibility for writing the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Figure S1: Plasma concentrations of soluble CD14 in naïve and SIV-infected macaques after chronic infection. sCD14 concentrations were determined using a sCD14 ELISA (R&D Systems). Box plots show 95th percentiles and median values. Dotted line shows limit of detection. (PPTX 45 KB)
Additional file 2: Figure S2: Analysis of multiparametric flow cytometry data for signature patterns of cytokine expression. Principal component analysis was used to determine any clustering of profiles of intracellular cytokine expression in SIV peptide-stimulated PBMC taken from macaques infected with SIV-rtTAΔnef and following withdrawal of dox (replication non-permissive, Group A) or following maintenance of dox (replication permissive, Group B) or infected with non-dox dependent SIVΔnef (replication permissive, Group C). PCI shows principal component scores accounting for as much variation in the original data as possible i.e. the transformed data from the 18 animals analysed. PCII accounts for much of the remaining variation as possible. Individual animal numbers are shown on the plot and their group designated by coloured symbols. (PPTX 64 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.